Symptom remission at 12-weeks strongly predicts long-term recovery from the first episode of psychosis.
Doody, Gillian A
Cambridge University Press
MetadataShow full item record
Dazzan, P., Lappin, J. M., Heslin, M., Donoghue, K., Lomas, B., Reininghaus, U., Onyejiaka, A., et al. (2020). Symptom remission at 12-weeks strongly predicts long-term recovery from the first episode of psychosis.. Psychological medicine, 50 (9), 1452-1462. https://doi.org/10.1017/s0033291719001399
BACKGROUND: To determine the baseline individual characteristics that predicted symptom recovery and functional recovery at 10-years following the first episode of psychosis. METHODS: AESOP-10 is a 10-year follow up of an epidemiological, naturalistic population-based cohort of individuals recruited at the time of their first episode of psychosis in two areas in the UK (South East London and Nottingham). Detailed information on demographic, clinical, and social factors was examined to identify which factors predicted symptom and functional remission and recovery over 10-year follow-up. The study included 557 individuals with a first episode psychosis. The main study outcomes were symptom recovery and functional recovery at 10-year follow-up. RESULTS: At 10 years, 46.2% (n = 140 of 303) of patients achieved symptom recovery and 40.9% (n = 117) achieved functional recovery. The strongest predictor of symptom recovery at 10 years was symptom remission at 12 weeks (adj OR 4.47; CI 2.60-7.67); followed by a diagnosis of depression with psychotic symptoms (adj OR 2.68; CI 1.02-7.05). Symptom remission at 12 weeks was also a strong predictor of functional recovery at 10 years (adj OR 2.75; CI 1.23-6.11), together with being from Nottingham study centre (adj OR 3.23; CI 1.25-8.30) and having a diagnosis of mania (adj OR 8.17; CI 1.61-41.42). CONCLUSIONS: Symptom remission at 12 weeks is an important predictor of both symptom and functional recovery at 10 years, with implications for illness management. The concepts of clinical and functional recovery overlap but should be considered separately.
This work was supported by UK Medical Research Council (ref: G0500817) and the Department of Health via the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley Foundation Trust (SLaM) and King’s College London
External DOI: https://doi.org/10.1017/s0033291719001399
This record's URL: https://www.repository.cam.ac.uk/handle/1810/299201
Attribution 4.0 International
Licence URL: https://creativecommons.org/licenses/by/4.0/